Company Monitoring Page for Anadys

latest headlines for company on cafepharma

3 Reasons Hep C Premiums Might Not Last
Motley Fool
Tue, 01/10/12 - 09:50 am
Tags:
hepatitis C, Anadys, Roche, Gilead, Pharmasset, Bristol-Myers Squibb, Inhibitex
Roche: New Era Of Hepatitis Therapies Creates Short-Term Threat, Long-Term Opportunity
Seeking Alpha
Sun, 10/23/11 - 10:49 am
Tags:
Roche, Anadys, hepatitis C, ANA773, Abbott Laboratories
Anadys acquisition sign of more to come
The Deal
Tue, 10/18/11 - 08:53 am
Tags:
Anadys, Roche, Merck, JNJ, Achillion, M&A, Indenix, Bristol-Myers Squibb
Roche's All-Oral Hep C Therapy Could Be First, Not Best, to Reach Market
TheStreet.com
Mon, 10/17/11 - 01:22 pm
Tags:
Roche, M&A, Anadys, hepatitis C, Pegasys, setrobuvir, Merck, Victrelis, RG7128, Pharmasset
Swiss pharma giant Roche to buy US-based hepatitis C specialist Anadys for $230 million
Yahoo/AP
Mon, 10/17/11 - 09:27 am
Tags:
Roche, M&A, Anadys, hepatitis C
Hep C Drug Updates: Vertex and Anadys
TheStreet.com
Thu, 10/13/11 - 12:21 pm
Tags:
Vertex, Anadys, hepatitis C, Incivek, setrobuvir
12 Cancer Stocks Being Snapped Up by Insiders
Seeking Alpha
Fri, 08/19/11 - 12:09 pm
Tags:
OPKO Health, Tengion, GTx, Anadys, Complete Genomics, Amag Pharmaceuticals, MannKind, Threshold Pharmaceuticals, Synta, Genomic Health, Ziopharm, Ardea
ANA598 Data Presented at AASLD Highlight Positive Clinical Profile of DAA Entering Phase IIb
Yahoo/PR NewsWire
Sat, 10/30/10 - 12:16 pm
Tags:
hepatitis C, Anadys, ANA598
15 Biotech Stocks With the Lowest Put/Call Ratios
Seeking Alpha
Wed, 10/13/10 - 12:09 pm
Tags:
biotech, Anadys, BioSante, Cerus, CompuGen, Cytokinetics, Cell Therapeutics, Idera Pharmaceuticals, Medivation, MDRA, RXi Pharmaceuticals, Sangamo BioSciences, Talecris, 3SBio, Vical, Trimeris
Anadys mulls strategic options on hepatitis C drug
Yahoo/AP
Thu, 05/27/10 - 10:29 am
Tags:
Anadys, hepatitis C
Spotlight on Anadys, Keryx as biotechs' shares trade higher
MarketWatch
Sat, 05/22/10 - 09:39 am
Tags:
Anadys, Keryx, biotech
Abbott falls on acquisition deal; Anadys climbs
Marketwatch
Fri, 05/21/10 - 11:14 am
Tags:
Abbott Laboratories, Anadys, M&A, Piramal Healthcare
Biotech Calendar: Key Dates for April
TheStreet.com
Mon, 04/5/10 - 09:53 am
Tags:
Forest Labs, Celgene, Genzyme, Lexicon Pharmaceuticals, Cell Therapeutics, Acadia, Acorda Therapeutics, Vertex Pharmaceuticals, Indenix, Pozen, Acura Pharmaceuticals, OSI Pharmaceuticals, Cyclacel, Peregrine Pharmaceuticals, Anadys, Pharmasset, Dendreon
Anadys study results show little difference between hepatitis C drug, placebo; shares slide
Yahoo/AP
Thu, 02/25/10 - 09:06 am
Tags:
hepatitis C, Anadys
Anadys Pharmaceuticals Provides Progress Update On Phase II Study Of ANA598 In Hepatitis C Patients
Medical News Today
Sat, 01/23/10 - 11:29 am
Tags:
Anadys, hepatitis C
FDA Calendar Updates: Anadys, Merck, Schering-Plough
Seeking Alpha
Fri, 07/31/09 - 08:17 am
Tags:
FDA, Merck, Schering Plough, Anadys
Anadys Financing Tempers Hope for Hep C Deal
TheStreet.com
Thu, 06/4/09 - 10:47 am
Tags:
Anadys, hepatitis C, ANA598
Anadys Pharmaceuticals to Report First Quarter 2009 Financial Results
Yahoo
Sat, 04/18/09 - 11:33 am
Tags:
Anadys
Anadys Tries to Tempt Suitors With Hep C Data
TheStreet.com
Tue, 04/7/09 - 05:04 am
Tags:
Anadys, hepatitis C
Looking for the Biotech Breakout
Seeking Alpha
Mon, 01/19/09 - 09:13 am
Tags:
biotech, Biotech Ishares, Anadys, Cypress Bioscience, CV Therapeutics, Valeant Pharmaceuticals, Illumina, Biogen Idec, Life Technologies, Sequenom, Biomarin

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.